Purchase Order 75N91020P00792

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $13,879.50 in biological kits, with an award date of June 13, 2019 and completion date of July 13, 2019. Place of performance is Carlsbad, California. The order is priced on a firm fixed price basis with no set-aside designation.</p>

<p>The National Cancer Institute issued a purchase order to Life Technologies Corporation for biological kits valued at $13,697.04, awarded July 9, 2019, with ultimate completion August 8, 2019. Place of performance is Carlsbad, California. The order carries firm fixed price commercial item pricing with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $20,776.50 on September 5, 2019, with completion by October 5, 2019. Place of performance is Carlsbad, California. The order represents a firm fixed-price, commercial purchase of laboratory instrumentation, reagents, or consumables—Life Technologies' core federal offering in genetic analysis and molecular biology. No set-aside was applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab supplies on August 29, 2017, with a ceiling value of $14,198.40 and completion date of September 28, 2017. Performance occurs in Carlsbad, California. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $10,146.00 on July 25, 2017, for laboratory supplies with ultimate completion on August 23, 2017. Place of performance is Carlsbad, California. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute issued a purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) valued at $10,412.00 on July 1, 2020, for biological kits. Place of performance is Carlsbad, California. The order is firm fixed price with an ultimate completion date of July 31, 2020. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation valued at $19,953.15 on July 26, 2017, for lab supplies with firm fixed pricing and no set-aside designation. Place of performance is Carlsbad, California. The order completes on August 24, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $22,130 in lab equipment on June 9, 2021, with completion by July 9, 2021. The award carries no small business set-aside. Performance is in Carlsbad, California. The order is firm fixed price and was issued to de-obligate expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 close of the period of availability.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $14,621.46 on November 20, 2019, with an ultimate completion date of December 19, 2019. The order procures drugs and biologicals on a firm fixed-price basis. Place of performance is Grand Island, New York.</p>